Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery
NCT ID: NCT06810375
Last Updated: 2025-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
120 participants
INTERVENTIONAL
2025-03-01
2029-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Erector Spinae Plane Block With Bupivacaine for Medical Thoracoscopy
NCT06313632
RCT Comparing ESPB Solutions in Breast Surgery
NCT04603911
Erector Spinae Plane (ESP) Block vs Intravenous Lignocaine Infusion in (VATS)
NCT06289790
Erector Spinae Plane Block Versus Conventional Analgesia in Complex Spine Surgery
NCT04156581
Thoracic Surgery Intercostal Block Trial With Liposomal vs. Hydrochloride Bupivacaine
NCT07134660
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Preoperative Erector Spinae Block (ESB)(Bupivacaine)(Marcaine®)
Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)
preoperative erector spinae block with bupivacaine (Marcaine®)
Intercostal nerve block
intraoperative intercostal nerve block with liposomal bupivacaine (Exparel®)
Intraoperative Intercostal Nerve Block (INB)(Liposomal Bupivacaine)(Exparel®)
Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)
preoperative erector spinae block with bupivacaine (Marcaine®)
Intercostal nerve block
intraoperative intercostal nerve block with liposomal bupivacaine (Exparel®)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)
preoperative erector spinae block with bupivacaine (Marcaine®)
Intercostal nerve block
intraoperative intercostal nerve block with liposomal bupivacaine (Exparel®)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patient undergoing bilateral surgery
* Surgery is emergent as deemed by the principal investigator
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
George Washington University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Akhil Patel
MD, Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The George Washington University Hospital
Washington D.C., District of Columbia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCR246143
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.